From a practical standpoint, however, deciding whether an individual tumor specimen is “positive for CDKN2A homozygous deletion” for grading purposes requires a defined cutoff value for the percentage of cells with homozygous deletion by FISH. The gene discussed is CDKN2A; the disease is neoplasm.